CNR1 Gene
Introduction
Pathway Diagram
flowchart TD
CNR1["CNR1 Cannabinoid Receptor 1"]
CB1_signaling["Cannabinoid CB1 Receptor Signalling"]
PPARG["PPARG Activation"]
inflammation["Inflammation"]
oxidative_stress["Oxidative Stress"]
MAPK["MAPK Pathway"]
IL1B["IL1B"]
IL6["IL6"]
TP53["TP53"]
neurodegeneration["Neurodegeneration"]
ALS["Amyotrophic Lateral Sclerosis"]
dementia["Dementia"]
neuroprotection["Neuroprotection"]
CNR1 -->|"mediates"| CB1_signaling
CNR1 -->|"activates"| PPARG
CNR1 -->|"regulates"| inflammation
CNR1 -->|"causes"| oxidative_stress
CNR1 -->|"regulates"| MAPK
CNR1 -->|"regulates"| IL1B
CNR1 -->|"regulates"| IL6
CNR1 -->|"regulates"| TP53
inflammation -->|"promotes"| neurodegeneration
oxidative_stress -->|"drives"| neurodegeneration
PPARG -->|"provides"| neuroprotection
neurodegeneration -->|"leads to"| ALS
neurodegeneration -->|"leads to"| dementia
classDef central fill:#006494,color:#e0e0e0
classDef protective fill:#1b5e20,color:#e0e0e0
classDef pathological fill:#ef5350,color:#0d0d1a
classDef regulatory fill:#4a1a6b,color:#e0e0e0
classDef outcomes fill:#5d4400,color:#e0e0e0
class CNR1 central
class PPARG,neuroprotection protective
class inflammation,oxidative_stress,neurodegeneration pathological
class CB1_signaling,MAPK,IL1B,IL6,TP53 regulatory
class ALS,dementia outcomes
...
CNR1 Gene
Introduction
Pathway Diagram
Mermaid diagram (expand to render)
<table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">CNR1 Gene</th> </tr> <tr> <td class="label">Gene Symbol </td> <td>CNR1</td> </tr> <tr> <td class="label">Full Name </td> <td>Cannabinoid Receptor 1</td> </tr> <tr> <td class="label">Chromosomal Location </td> <td>6q25.2</td> </tr> <tr> <td class="label">NCBI Gene ID </td> <td>1268</td> </tr> <tr> <td class="label">OMIM </td> <td>114010</td> </tr> <tr> <td class="label">Ensembl ID </td> <td>ENSG00000118432</td> </tr> <tr> <td class="label">UniProt ID </td> <td>P21554</td> </tr> <tr> <td class="label">Associated Diseases </td> <td>Cannabis Use Disorder, Schizophrenia, [Parkinson's Disease](/diseases/parkinsons-disease-disease), Alzheimer's Disease</td> </tr> </table>
Cnr1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Function The CNR1 gene encodes the cannabinoid receptor type 1 (CB1), a G protein-coupled receptor that is the most abundant cannabinoid receptor in the brain. It is the primary target of Δ9-tetrahydrocannabinol (THC), the psychoactive component of cannabis.
Normal Function
Couples to Gi/o proteins to inhibit adenylyl cyclase
Modulates neurotransmitter release (glutamate, GABA, dopamine)
Involved in appetite regulation and energy metabolism
Plays role in memory and learning (especially forgetting)
Regulates pain perception and emotional responses
Disease Associations
Addiction Disorders
Cannabis Use Disorder : CNR1 variants associated with cannabis dependence
Reward processing : Altered endocannabinoid signaling in addiction
Neurological Disorders
Schizophrenia : Genetic associations with psychosis risk
Parkinson's Disease : CB1 receptor changes in basal ganglia, potential therapeutic target
Alzheimer's Disease : Endocannabinoid system alterations, neuroprotective potential
Movement Disorders
Huntington's Disease : CB1 receptor loss in basal ganglia
Multiple System Atrophy : Dysregulated endocannabinoid signaling
Expression Pattern CNR1 is highly expressed in:
Basal ganglia (globus pallidus, substantia nigra pars reticulata)
Cerebellum (Purkinje cells)
[Hippocampus](/brain-regions/hippocampus) (CA1-CA3 regions)
[Cortex](/brain-regions/cortex) (layers II-IV)
[Hypothalamus](/brain-regions/hypothalamus)
Therapeutic Targeting
Current Approaches
CB1 antagonists : Rimonabant (withdrawn for psychiatric side effects)
Fatty acid amide hydrolase (FAAH) inhibitors : Increase anandamide levels
Drug Development
Peripherally-restricted CB1 antagonists
Allosteric modulators
CB1 agonists for appetite stimulation (cachexia)
Key Publications
Mackie K. (2006). Cannabinoid receptors . Annu Rev Pharmacol Toxicol. PMID: 16402910 (https://pubmed.ncbi.nlm.nih.gov/16402910/)
Di Marzo V. (2008). Endocannabinoid signaling . Nat Rev Neurosci. PMID: 18426499 (https://pubmed.ncbi.nlm.nih.gov/18426499/)
Hurd YL. (2017). Cannabis and the developing brain . Nat Rev Neurosci. PMID: 28968186 (https://pubmed.ncbi.nlm.nih.gov/28968186/)
See Also
[Cannabinoid Receptor](/entities/cannabinoid-receptors)
[Endocannabinoid System](/mechanisms/endocannabinoid-system)
[Cannabis Use Disorder](/diseases/cannabis-use-disorder)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Huntington's Disease](/diseases/huntingtons)
[Schizophrenia](/diseases/schizophrenia)
External Links
[NCBI Gene: CNR1](https://www.ncbi.nlm.nih.gov/gene/1268)
[UniProt: CNR1](https://www.uniprot.org/uniprot/P21554)
[OMIM: CNR1](https://www.omim.org/entry/114010)
Endocannabinoid System
CB1 Receptor Signaling The CNR1 gene encodes the CB1 cannabinoid receptor:
G Protein Coupling : Gi/o protein-coupled receptor
Second Messengers : Inhibits adenylate cyclase, activates MAPK pathways
Ion Channels : Modulates calcium and potassium channels
Presynaptic Effects : Regulates neurotransmitter release
Endocannabinoid Ligands CB1 responds to endogenous cannabinoids:
Anandamide (AEA)
2-Arachidonoylglycerol (2-AG)
N-Arachidonoyl dopamine (NADA)
Neuroprotective Mechanisms
Anti-Excitotoxicity CB1 receptor activation provides neuroprotection through:
Reduced glutamate release
Decreased calcium influx
Activation of protective signaling pathways
Anti-Inflammation
Suppression of microglial activation
Reduced cytokine production
Modulation of neuroinflammatory responses
Autophagy Regulation
Promotes [autophagy](/entities/autophagy) in [neurons](/entities/neurons)
Clearance of protein aggregates
Mitochondrial quality control
Therapeutic Implications
Drug Targets
CB1 receptor agonists (dronabinol, nabilone)
CB1 receptor antagonists (rimonabant)
Allosteric modulators
FAAH inhibitors (increase endocannabinoids)
Clinical Applications
Appetite stimulation
Pain management
Epilepsy treatment
Multiple sclerosis
Neurodegenerative diseases
Background The study of Cnr1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Mackie K, (2006) (2006)
Di Marzo V, (2008) (2008)
Hurd YL, (2017) (2017)
Piazza PV, et al, (2020) (2020)
Fernández-Ruiz J, et al, (2000) (2000)
García-González D, et al, (2019) (2019)
Walther S, et al, (2019) (2019)
Chiarlone A, et al, (2014) (2014)
Pathway Diagram The following diagram shows the key molecular relationships involving CNR1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description